October 11th 2024
Aseptic fill/finish of biopharmaceuticals requires an understanding of the structure and limitations of each molecule.
Hospira Recalls Labetalol Hydrochloride Due to Cracked Vials
February 23rd 2018The company is voluntarily recalling three lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial and one lot of Labetalol Hydrochloride Injection, USP, Novaplus because of the potential of cracked glass at the rim of the vials.